Literature DB >> 15959466

Neurosteroids: endogenous regulators of the GABA(A) receptor.

Delia Belelli1, Jeremy J Lambert.   

Abstract

GABA(A) (gamma-aminobutyric acid type A) receptors mediate most of the 'fast' synaptic inhibition in the mammalian brain and are targeted by many clinically important drugs. Certain naturally occurring pregnane steroids can potently and specifically enhance GABA(A) receptor function in a nongenomic (direct) manner, and consequently have anxiolytic, analgesic, anticonvulsant, sedative, hypnotic and anaesthetic properties. These steroids not only act as remote endocrine messengers, but also can be synthesized in the brain, where they modify neuronal activity locally by modulating GABA(A) receptor function. Such 'neurosteroids' can influence mood and behaviour in various physiological and pathophysiological situations, and might contribute to the behavioural effects of psychoactive drugs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15959466     DOI: 10.1038/nrn1703

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  388 in total

1.  Genotype Differences in Sensitivity to the Anticonvulsant Effect of the Synthetic Neurosteroid Ganaxolone during Chronic Ethanol Withdrawal.

Authors:  Michelle A Nipper; Jeremiah P Jensen; Melinda L Helms; Matthew M Ford; John C Crabbe; David J Rossi; Deborah A Finn
Journal:  Neuroscience       Date:  2018-12-02       Impact factor: 3.590

Review 2.  Fragile X syndrome: the GABAergic system and circuit dysfunction.

Authors:  Scott M Paluszkiewicz; Brandon S Martin; Molly M Huntsman
Journal:  Dev Neurosci       Date:  2011-09-21       Impact factor: 2.984

Review 3.  GABA receptor-mediated effects in the peripheral nervous system: A cross-interaction with neuroactive steroids.

Authors:  Valerio Magnaghi; Marinella Ballabio; Antonio Consoli; Jeremy J Lambert; Ilaria Roglio; Roberto C Melcangi
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

4.  Subregion-Specific Impacts of Genetic Loss of Diazepam Binding Inhibitor on Synaptic Inhibition in the Murine Hippocampus.

Authors:  Connor D Courtney; Catherine A Christian
Journal:  Neuroscience       Date:  2018-07-19       Impact factor: 3.590

5.  Neurosteroid analogues. 18. Structure-activity studies of ent-steroid potentiators of γ-aminobutyric acid type A receptors and comparison of their activities with those of alphaxalone and allopregnanolone.

Authors:  Mingxing Qian; Kathiresan Krishnan; Eva Kudova; Ping Li; Brad D Manion; Amanda Taylor; George Elias; Gustav Akk; Alex S Evers; Charles F Zorumski; Steven Mennerick; Douglas F Covey
Journal:  J Med Chem       Date:  2013-12-24       Impact factor: 7.446

6.  Exogenous progesterone exacerbates running response of adolescent female mice to repeated food restriction stress by changing α4-GABAA receptor activity of hippocampal pyramidal cells.

Authors:  G S Wable; Y-W Chen; S Rashid; C Aoki
Journal:  Neuroscience       Date:  2015-09-14       Impact factor: 3.590

7.  Chronic ethanol drinking increases during the luteal menstrual cycle phase in rhesus monkeys: implication of progesterone and related neurosteroids.

Authors:  Brandy L Dozier; Cara A Stull; Erich J Baker; Matthew M Ford; Jeremiah P Jensen; Deborah A Finn; Kathleen A Grant
Journal:  Psychopharmacology (Berl)       Date:  2019-01-15       Impact factor: 4.530

Review 8.  Extrasynaptic GABAA receptors in the crosshairs of hormones and ethanol.

Authors:  Istvan Mody
Journal:  Neurochem Int       Date:  2007-07-17       Impact factor: 3.921

Review 9.  Divergent neuroactive steroid responses to stress and ethanol in rat and mouse strains: relevance for human studies.

Authors:  Patrizia Porcu; A Leslie Morrow
Journal:  Psychopharmacology (Berl)       Date:  2014-04-26       Impact factor: 4.530

10.  Neurosteroid allopregnanolone reduces ipsilateral visual cortex potentiation following unilateral optic nerve injury.

Authors:  Elena G Sergeeva; Claudia Espinosa-Garcia; Fahim Atif; Machelle T Pardue; Donald G Stein
Journal:  Exp Neurol       Date:  2018-05-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.